期刊文献+

慢性阻塞性肺疾病合并支气管扩张症患者临床特征及预后相关因素分析 被引量:26

Clinical characteristics of chronic obstructive pulmonary disease patients with bronchiectasis and its related prognostic factors analysis
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)合并支气管扩张症患者的临床特征及预后相关因素。方法收集330例COPD患者分为A组(单纯COPD患者)和B组(COPD合并支气管扩张症患者)。根据不同预后结果将COPD合并支气管扩张患者分为存活组与死亡组,通过回归分析筛查影响COPD合并支气管扩张症患者预后的相关因素。结果 A组与B组在体质量指数、肺结核病史、症状持续时间、痰色方面比较,差异有统计学意义(P <0. 05); A组的用力肺活量占预计值百分比(FVC%预计值)、第1秒用力呼气容积占预计值百分比(FEV1%预计值)、第1秒用力呼气容积占用力肺活量百分比(FEV1/FVC)、血氧分压[p(O_2)]和白蛋白水平显著高于B组(P <0. 05); A组的二氧化碳分压[p(CO_2)]、血红蛋白(Hb)、红细胞沉降率(ESR)水平显著低于B组(P <0. 05)。B组中有33例患者死亡,病死率为22. 76%。单因素分析结果显示,年龄、症状持续时间、p(CO_2)、白蛋白是影响COPD合并支气管扩张患者预后的相关因素;二元Logistic回归分析结果显示,年龄、白蛋白水平、症状持续时间是影响COPD合并支气管扩张症患者生存状况的危险因素(P <0. 05或P <0. 01)。结论COPD合并支气管扩张症患者的预后与年龄、白蛋白、症状持续时间密切相关,需注意监测患者白蛋白水平的变化。 Objective To explore the clinical characteristics of patients with chronic obstructive pulmonary disease(COPD)complicated with bronchiectasis,and analyze the its prognostic factors.Methods A total of 330 COPD cases in our hospital were divided into group A(simple COPD)and group B(COPD and bronchiectasis)which were divided into survival group and death group according to different prognostic results.The influencing factors of prognosis in COPD patients with bronchiectasis were analyzed by regression analysis.Results There were significant differences in body mass index,history of tuberculosis,duration of symptoms and sputum color between group A and group B(P<0.05).The percentage of forced vital capacity to predicted value(FVC%predicted value),percentage of forced expiratory volume in the first second to predicted value(FEV1%predicted value),ratio of forced expiratory volume in the first second to forced vital capacity(FEV1/FVC predicted value),partial pressure of blood oxygen[p(O2)]and albumin level in group A were higher than those in group B(P<0.05).The levels of partial pressure of blood carbon dioxide[p(CO2)],hemoglobin(Hb)and erythrocyte sedimentation rate(ESR)in group A were lower than those in group B(P<0.05).There were 33 patients died in group B,with a mortality rate of 22.76%.Univariate analysis showed that age,duration of symptoms,p(CO2)and albumin were related factors for the prognosis of COPD patients with bronchiectasis,and binary logistic regression analysis showed that age,albumin and duration of symptoms were risk factors for death of COPD patients with bronchiectasis(P<0.05 or P<0.01).Conclusion The prognosis of COPD patients with bronchiectasis is closely related to age,albuminand duration of symptoms,and albumin level should be monitored.
作者 陈伟 马强 朱镇镇 CHEN Wei;MA Qiang;ZHU Zhenzhen(Department of Respiratory Medicine,Yan'an Traditional Chinese Medicine Hospital,Yan'an,Shanxi,716000;Department of Respiratory and Tuberculosis,Yan'an Second People's Hospital,Yan'an,Shaanxi,716000)
出处 《实用临床医药杂志》 CAS 2019年第7期72-75,共4页 Journal of Clinical Medicine in Practice
基金 国家自然科学基金资助面上课题(81570072)
关键词 支气管扩张症 肺疾病 慢性阻塞性 临床特征 预后 bronchiectasis pulmonary disease chronic obstruction clinical features prognosis
  • 相关文献

参考文献19

二级参考文献172

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 4Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 5Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 6冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 7Woodhead M, Blasi F, Ewig S, et al. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J,2005,26 : 1138-1180.
  • 8Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections - - full version. Clin Microbiol Infect, 2011, 17 Suppl 6: El-E59.
  • 9Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax,2010,65 Suppl 1 :i1- 58.
  • 10Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Am J Respir Cfit Care Med, 2004,169 : A330.

共引文献8976

同被引文献274

引证文献26

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部